Kestra Advisory Services’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,908
Closed -$222K 2138
2021
Q3
$222K Buy
1,908
+150
+9% +$17.5K ﹤0.01% 1909
2021
Q2
$390K Sell
1,758
-802
-31% -$178K ﹤0.01% 1414
2021
Q1
$338K Sell
2,560
-401
-14% -$52.9K ﹤0.01% 1388
2020
Q4
$516K Buy
2,961
+2,926
+8,360% +$510K 0.01% 1191
2020
Q3
$290K Buy
+35
New +$290K 0.01% 1135